MY ACCOUNT | NEWSLETTER |

Vet vaccines market to exceed $13B


The international market for veterinary vaccines is forecast to reach a value of $13.09 billion by 2031, according to a report by market research firm, Growth Plus Market Reports. North America is expected to hold the largest share of the market. 

Growth across the marketplace is forecast based on the uptick in both populations of companion animals and for livestock animals as demand has increased for animal-based products. At the same time, efforts to keep livestock safe amid an increased prevalence of zoonotic disease cases.

A significant driver in the market is a spike in the adoption of companion animals that has then spurred an increase in veterinary care utilization, including receiving vaccinations. In 2019 to 2020, the majority of homes in the US (67%) had a pet, according to American Pet Products Association.

Growth across the global veterinary vaccines market could be tempered by the cost of development of vaccines and later in the process of handling and storage of vaccines. This aspect is further affected by government regulations on ingredients and shipment across regions. 

Vaccination demand for companion animals is expected to outpace that of livestock. This is thought to be based on the number of companion animals as well as the close proximity of pets to people.


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top